January 23, 2025
Introduction:
Snake bites pose health crisis in India, claiming approximately 58,000 lives annually. The country is often referred to as the ‘snakebite capital’ of the world. This alarming statistic puts stress on the urgent need for effective prevention and treatment strategies.
About Snake Venom
- Snake venom is a complex mixture of proteins that helps snakes immobilize the prey and defend against threats
- It contains various toxins that affect the body in different ways.
- Haemotoxins destroy blood cells, neurotoxins disrupt nerve signals, and cytotoxins damage tissues. Without prompt medical intervention, snakebites can lead to death.
What Are Antivenoms?
Antivenoms, or antivenins, are crucial for treating snakebites. They are created by injecting venom into animals, typically horses, which then produce specific antibodies. These antibodies neutralise the venom’s harmful effects, allowing the body to recover. The effectiveness of antivenom depends on the type of snake and the amount of venom injected.
Production of Antivenoms
The production process involves capturing venomous snakes and extracting their venom. Horses are immunised with controlled doses of venom, prompting antibody production. These antibodies are then extracted from the horse’s blood and purified into antivenoms. This method has been in use since the late 19th century and remains vital .
The Role of the Irula Tribe
The Irula tribe in Tamil Nadu plays role in antivenom production. They are skilled snake-catchers, ensuring a consistent supply of high-quality venom. Their expertise is essential for maintaining the supply chain of antivenoms in India, denoting the intersection of traditional knowledge and modern medicine.
Prevalence of Snakebites in India
- India is home to over 300 snake species, with more than 60 being venomous.
- The ‘Big Four’ snakes—Indian cobra, common krait, Russell’s viper, and saw-scaled viper—are responsible for most fatalities.
- However, other venomous species pose risks, and existing polyvalent antivenoms may not be effective against them.
Challenges in Accessing Antivenoms
Despite being the largest producer of antivenoms, access remains a challenge. Many rural areas lack immediate healthcare facilities, forcing victims to travel long distances. Additionally, logistical issues, cultural beliefs, and inadequate storage conditions can hinder effective treatment. The high cost of antivenom production further limits accessibility for the economically disadvantaged.
Innovations in Antivenom Development
Scientists are exploring recombinant DNA technology to create synthetic antivenoms that are safer and more effective. Artificial Intelligence is also being utilised to design tailored antivenoms, optimising their efficacy. Region-specific antivenoms could address the unique challenges posed by different snake species.
Future Directions
The future of antivenom treatment is evolving. Ongoing research aims to improve diagnostic tools and develop portable venom-detection kits. These innovations can enhance the timely administration of antivenoms, potentially reducing the mortality rate from snakebites. Continued investment in research and infrastructure is crucial for addressing this public health crisis effectively.
,